Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Medication Overuse Prevalent Among US Migraine Patients

Publish date:: September 10, 2019

Key clinical point: Medication overuse is prevalent among U.S. migraine patients and significantly links with impaired function and disability.

Major finding: Medication overuse occurred in 18% of surveyed U.S. residents who met the study’s definition of having migraine.

Study details: Analysis of survey results from the CaMEO study, with 16,789 U.S. residents identified with migraine.

Disclosures: CaMEO was funded by Allergan. Dr. Schwedt has been a consultant to Allergan, and also to Alder, Amgen, Cipla, Dr. Reddy’s, Ipsen, Lilly, Novartis, and Teva; he had stock ownership in Aural Analytics, Nocira, and Second Opinion; and he has received research funding from Amgen.

Citation:

Schwedt TJ et al. Headache. 2019 June;59[S1]:83-4, Abstract P92

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,